0.7625
Precedente Chiudi:
$0.699
Aprire:
$0.71
Volume 24 ore:
954.62K
Relative Volume:
1.47
Capitalizzazione di mercato:
$58.62M
Reddito:
$222.00K
Utile/perdita netta:
$-22.92M
Rapporto P/E:
-0.5295
EPS:
-1.44
Flusso di cassa netto:
$-15.47M
1 W Prestazione:
+8.93%
1M Prestazione:
+15.58%
6M Prestazione:
-42.67%
1 anno Prestazione:
-43.52%
Envoy Medical Inc Stock (COCH) Company Profile
Nome
Envoy Medical Inc
Settore
Industria
Telefono
651-361-8000
Indirizzo
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
COCH
Envoy Medical Inc
|
0.7625 | 53.74M | 222.00K | -22.92M | -15.47M | -1.44 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-24 | Iniziato | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Borsa (COCH) Ultime notizie
Envoy Medical Completes Enrollment for Acclaim Fully Implanted Cochlear Implant Trial - The Hearing Review
Enrollment Complete in Study Evaluating Fully Implanted Cochlear Implant - Medical Product Outsourcing
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant - TMX Newsfile
EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear - Benzinga
Quarterly Trades: Is Envoy Medical Inc showing insider buyingCEO Change & Scalable Portfolio Growth Methods - baoquankhu1.vn
COCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COCH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Envoy Medical Regains Nasdaq Listing Compliance After Financing - TipRanks
Envoy Medical (NASDAQ: COCH) regains compliance with Nasdaq listing rule - Stock Titan
Revenue Check: Can Envoy Medical Inc Equity Warrant be the next market leaderQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Envoy Medical secures three new patents, bolstering cochlear implant leadership - Indian Pharma Post
Envoy Medical Nears Enrollment Completion for Acclaim Cochlear Implant Trial - The Hearing Review
Envoy Medical regains Nasdaq compliance after balance sheet work - Investing.com Australia
Envoy Medical (COCH) Price Target Increased by 15.15% to 9.69 - Nasdaq
Envoy Medical regains Nasdaq compliance after balance sheet work By Investing.com - Investing.com South Africa
COCHW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - TMX Newsfile
Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan
Envoy Medical receives three new patents for cochlear implant tech By Investing.com - Investing.com India
Envoy Medical receives three new patents for cochlear implant tech - Investing.com Australia
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - marketscreener.com
Does Envoy Medical Inc. stock benefit from AI growthTrade Analysis Summary & High Win Rate Trade Alerts - mfd.ru
What are analysts’ price targets for Envoy Medical Inc.July 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - The Globe and Mail
Envoy Medical raises $30 million, nears completion of cochlear implant trial By Investing.com - Investing.com South Africa
Analyzing Envoy Medical (NASDAQ:COCH) and TearLab (OTCMKTS:TEAR) - Defense World
Envoy Medical raises $30 million, nears completion of cochlear implant trial - Investing.com Nigeria
Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan
Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st
Envoy Medical interim CFO buys $85k in shares - Investing.com Nigeria
Envoy Medical interim CFO buys $85k in shares By Investing.com - Investing.com Canada
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock - Investing.com
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com Australia
Envoy Medical (COCH) investor details 84.8% beneficial ownership stake - Stock Titan
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - marketscreener.com
Can Envoy Medical Inc. Equity Warrant continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - mfd.ru
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN
Envoy Medical Closes Upsized Public Offering to Fund Growth - TipRanks
Envoy Medical Signs Multiple Financing Agreements - TradingView
Is Envoy Medical Inc. Equity Warrant stock gaining market share2025 Dividend Review & Daily Profit Maximizing Tips - mfd.ru
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering - TradingView
Is Envoy Medical Inc. stock risky to hold now2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Envoy Medical Grants Stock Options to Key Executives - TipRanks
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering - TMX Newsfile
Envoy Medical Inc Azioni (COCH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):